Search results
Moderna to present combo COVID-flu vaccine to regulators after trial
AOL· 4 days agoModerna announced on Monday that its combination COVID-19 and flu mRNA-1083vaccine trial showed "promising" results and that the company would soon present its findings to ...
Covid-flu combination vaccine shows positive results in late-stage trial, Moderna says - WSVN 7News...
7 News Miami· 4 days agoOn Monday, vaccine maker Moderna announced positive late-stage trial results for its Covid-flu...
Moderna’s New Flu-COVID Combi mRNA Vaccine Outperforms Separate Shots In Trials
IFLScience· 3 days agoThe data are yet to be submitted for publication in a peer-reviewed journal, but the company says...
Moderna's combo Covid, flu vaccine meets goals in late-stage study - Boston Business Journal
The Business Journals· 4 days agoModerna Inc. is making steady headway on its plan to launch all four products from its respiratory ...
Moderna's two-in-one flu and Covid vaccine passes advanced trial
BBC News· 4 days agoDrug company Moderna says its combined flu and Covid vaccine, which targets the two diseases in a...
Moderna's COVID-flu combo shot outperformed existing vaccines in a late-stage trial
Quartz· 4 days agoIt could also help Moderna offset declining demand for COVID-19 vaccines. “Combination vaccines have...
Moderna price target raised at Oppenheimer after RSV vaccine approval By Investing.com
Investing.com· 2 days agoModerna price target raised at Oppenheimer after RSV vaccine approval
Moderna's combination Covid, flu vaccine is more effective than existing shots in late-stage trial
NBC Los Angeles· 4 days agoModerna said its combination vaccine targeting Covid and the flu was more effective than existing...
Moderna's combination Covid, flu vaccine is more effective than existing shots in late-stage trial
NBC Miami· 4 days agoModerna said its combination vaccine targeting Covid and the flu was more effective than existing...
Why Moderna Stock Is a No-Brainer Buy Right Now | The Motley Fool
The Motley Fool· 4 days agoIn 2022, the biotech company generated sales of nearly $18.9 billion, but it expects revenue of only...